Arid
DOI10.1186/s12967-021-03002-1
Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis
Zeng, Zihang; Li, Jiali; Zhang, Jianguo; Li, Yangyi; Liu, Xingyu; Chen, Jiarui; Huang, Zhengrong; Wu, Qiuji; Gong, Yan; Xie, Conghua
通讯作者Xie, CH (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Peoples R China. ; Gong, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Biol Repositories, Wuhan, Peoples R China.
来源期刊JOURNAL OF TRANSLATIONAL MEDICINE
EISSN1479-5876
出版年2021
卷号19期号:1
英文摘要BackgroundTumor microenvironment (TME) is associated with tumor progression and prognosis. Previous studies provided tools to estimate immune and stromal cell infiltration in TME. However, there is still a lack of single index to reflect both immune and stromal status associated with prognosis and immunotherapy responses.MethodsA novel immune and stromal scoring system named ISTMEscore was developed. A total of 15 datasets were used to train and validate this system, containing 2965 samples from lung adenocarcinoma, skin cutaneous melanoma and head and neck squamous cell carcinoma.ResultsThe patients with high immune and low stromal scores (HL) were associated with low ratio of T cell co-inhibitory/stimulatory molecules and low levels of angiogenesis markers, while the patients with low immune and high stromal scores (LH) had the opposite characteristics. The HL patients had immune-centered networks, while the patients with low immune and low stromal scores (LL) had desert-like networks. Moreover, copy number alteration burden was decreased in the HL patients. For the clinical characteristics, our TME classification was an independent prognostic factor. In the 5 cohorts with immunotherapy, the LH patients were linked to the lowest response rate.ConclusionsISTMEscore system could reflect the TME status and predict the prognosis. Compared to previous TME scores, our ISTMEscore was superior in the prediction of prognosis and immunotherapy response.
英文关键词Tumor microenvironment Multi-task learning Scoring system Prognosis Immunotherapy
类型Article
语种英语
开放获取类型Green Published, gold
收录类别SCI-E
WOS记录号WOS:000683729400003
WOS关键词LUNG ADENOCARCINOMA ; R PACKAGE ; EXPRESSION ; SURVIVAL ; VALIDATION ; PREDICTION ; SIGNATURE ; DISCOVERY ; CARCINOMA ; NIVOLUMAB
WOS类目Medicine, Research & Experimental
WOS研究方向Research & Experimental Medicine
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/364058
作者单位[Zeng, Zihang; Li, Jiali; Zhang, Jianguo; Li, Yangyi; Liu, Xingyu; Chen, Jiarui; Wu, Qiuji; Xie, Conghua] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Peoples R China; [Huang, Zhengrong; Gong, Yan] Wuhan Univ, Zhongnan Hosp, Dept Biol Repositories, Wuhan, Peoples R China; [Huang, Zhengrong; Gong, Yan] Wuhan Univ, Zhongnan Hosp, Hubei Engn Res Ctr, Tumor Precis Diag & Treatment Technol & Translat, Wuhan, Peoples R China; [Wu, Qiuji; Xie, Conghua] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Wuhan, Peoples R China; [Wu, Qiuji; Xie, Conghua] Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Wuhan, Peoples R China
推荐引用方式
GB/T 7714
Zeng, Zihang,Li, Jiali,Zhang, Jianguo,et al. Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis[J],2021,19(1).
APA Zeng, Zihang.,Li, Jiali.,Zhang, Jianguo.,Li, Yangyi.,Liu, Xingyu.,...&Xie, Conghua.(2021).Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis.JOURNAL OF TRANSLATIONAL MEDICINE,19(1).
MLA Zeng, Zihang,et al."Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis".JOURNAL OF TRANSLATIONAL MEDICINE 19.1(2021).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zeng, Zihang]的文章
[Li, Jiali]的文章
[Zhang, Jianguo]的文章
百度学术
百度学术中相似的文章
[Zeng, Zihang]的文章
[Li, Jiali]的文章
[Zhang, Jianguo]的文章
必应学术
必应学术中相似的文章
[Zeng, Zihang]的文章
[Li, Jiali]的文章
[Zhang, Jianguo]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。